Immunomedics, Inc.
Records under this name other than the patents Immunomedics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 83 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,285,977 | System and Method for Extension of the Bios Boot Specification now held by Dell Products L.P. In force · High confidence | In force | High confidence | |
| US 8,591,892 | FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death now held by Ohio State Innovation Foundation In force · High confidence | In force | High confidence | |
| US 10,377,829 | Isolated Nucleic Acid Encoding an ANTI-IGF-1R Antibody Term ended Ended no later than Jul 15, 2026 · Low confidence | Term ended | Ended no later than Jul 15, 2026 | Low confidence |
| US 7,531,327 | Methods and Compositions for Increasing Longevity and Protein Yield from a Cell Culture Term ended Ended no later than Jun 27, 2026 · Medium confidence | Term ended | Ended no later than Jun 27, 2026 | Medium confidence |
| US 8,722,047 | Humanized Anti-Hla-Dr Antibodies Term ended Term ended May 26, 2026 · High confidence | Term ended | Term ended May 26, 2026 | High confidence |
| US 9,751,948 | Novel Class of Monospecific and Bispecific Humanized Antibodies That Target the Insulin-Like Growth Factor Type I Receptor (IGF-1R) Term ended Ended no later than Mar 24, 2026 · Low confidence | Term ended | Ended no later than Mar 24, 2026 | Low confidence |
| US 8,992,917 | Humanized L243 Antibodies Term ended Term ended Mar 3, 2026 · Medium confidence | Term ended | Term ended Mar 3, 2026 | Medium confidence |
| US 9,187,561 | Humanized Anti-HLA-DR Antibodies Term ended Term ended Mar 3, 2026 · High confidence | Term ended | Term ended Mar 3, 2026 | High confidence |
| US 10,058,621 | Combination Therapy with Anti-Hla-Dr Antibodies and Kinase Inhibitors in Hematopoietic Cancers Term ended Term ended Mar 3, 2026 · High confidence | Term ended | Term ended Mar 3, 2026 | High confidence |
| US 10,174,114 | Humanized Anti-HLA-DR Antibodies Term ended Term ended Mar 3, 2026 · High confidence | Term ended | Term ended Mar 3, 2026 | High confidence |